459
Views
10
CrossRef citations to date
0
Altmetric
Drug Evaluations

Natalizumab for multiple sclerosis: appraising risk versus benefit, a seemingly demanding tango

, MD & , MD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Eleonora Cocco, Alberto Caoci, Lorena Lorefice & Maria Giovanna Marrosu. (2017) Perception of risk and shared decision making process in multiple sclerosis. Expert Review of Neurotherapeutics 17:2, pages 173-180.
Read now
Sirin Gandhi, Dejan Jakimovski, Rahil Ahmed, David Hojnacki, Channa Kolb, Bianca Weinstock-Guttman & Robert Zivadinov. (2016) Use of natalizumab in multiple sclerosis: current perspectives. Expert Opinion on Biological Therapy 16:9, pages 1151-1162.
Read now

Articles from other publishers (8)

Laura Zamarian, Thomas Berger, Marie‐Theres Pertl, Gabriel Bsteh, Atbin Djamshidian, Florian Deisenhammer & Margarete Delazer. (2020) Decision making and framing effects in multiple sclerosis. European Journal of Neurology 28:4, pages 1292-1298.
Crossref
L. Zamarian, M. Delazer, R. Ehling, M.‐T. Pertl, G. Bsteh, J. Wenter, S. Glatzl, C. Brenneis, T. Benke & T. Berger. (2018) Improvement of medical judgments by numerical training in patients with multiple sclerosis. European Journal of Neurology 26:1, pages 106-112.
Crossref
Mehdi Shahbazi, Mehdi Soltanzadeh-Yamchi & Mousa Mohammadnia-Afrouzi. (2018) T cell exhaustion implications during transplantation. Immunology Letters 202, pages 52-58.
Crossref
Antonio Giorgio & Nicola De Stefano. (2018) Effective Utilization of MRI in the Diagnosis and Management of Multiple Sclerosis. Neurologic Clinics 36:1, pages 27-34.
Crossref
Pei-Ran Ho, Harold Koendgen, Nolan Campbell, Bill Haddock, Sandra Richman & Ih Chang. (2017) Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies. The Lancet Neurology 16:11, pages 925-933.
Crossref
Bianca Weinstock-Guttman, Jesper Hagemeier, Katelyn S Kavak, Vasu Saini, Kara Patrick, Deepa P Ramasamy, Muhammad Nadeem, Ellen Carl, David Hojnacki & Robert Zivadinov. (2016) Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation. Journal of Neurology, Neurosurgery & Psychiatry 87:9, pages 937-943.
Crossref
Alexander C. Wiseman. (2016) Immunosuppressive Medications. Clinical Journal of the American Society of Nephrology 11:2, pages 332-343.
Crossref
Edward B. Thorp, Christian Stehlik & M. Javeed Ansari. (2015) T-cell exhaustion in allograft rejection and tolerance. Current Opinion in Organ Transplantation 20:1, pages 37-42.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.